After last week's 10% surge through the $411 ceiling, Broadcom has stalled at $416 and the question has shifted from whether the breakout holds to whether the September 2 earnings print can validate it.
The pullback is modest — down 1.5% Tuesday and barely half a percent on the week — but the peer tape tells a more complicated story. CEVA dropped 14.9% this week and RMBS shed 4.1%, while MRVL gave back 2.9%. AOSL bucked the move, adding 3.1%. The semiconductor complex that powered AVGO's breakout has fractured, which makes holding above $411 more meaningful, not less. The stock is now roughly 14% below its pre-earnings level of $479.23. The ground between here and September 2 is the question.
Short sellers have not returned to test the breakout, and the lending market confirms there is no bear conviction behind the week's dip. Short interest has fallen sharply — down 14% over the past week to 1.27% of the free float, the lowest reading in the 30-day window. The borrow market is completely unconstrained: availability is at maximum, cost to borrow is 0.27%, and it has fallen 26% over the past month. This is not a stock where bears are rebuilding positions. If anything, the short-covering trend that accompanied last week's rally has continued into this one.
Options positioning is marginally more defensive than its recent norm, but not dramatically so. The put/call ratio at 1.09 is slightly above its 20-day average of 1.07 — a z-score of just 0.6. The 52-week range runs from 0.89 to 1.23, so this week's reading is mid-range at best. Hedging into the September 2 date is present but not aggressive.
The Street backdrop is where the genuine tension lives. The bull case — dominant custom AI ASIC position, Google partnership, AI revenue ramp — is well understood and reflected in the analyst consensus: most major houses raised targets on June 4 after the Q2 print, with JPMorgan lifting to $580 and B of A to $530. The bear case is equally clear: the June 4 reaction was a 19.5% single-day drop, followed by another 13% fall on the Q2 report. Both post-earnings moves to the downside over the past year. The earnings history here carries real weight — the average day-one move has been a double-digit decline. The consensus price target of roughly $528 implies meaningful upside from current levels, but that gap has to survive whatever the September 2 report delivers on AI revenue guidance and gross margin trajectory. The valuation is not cheap: the stock trades at 25x trailing earnings and an EV/EBITDA of 20x, both drifting lower over the past 30 days as the stock has recovered but not fully reclaimed pre-earnings levels.
Insider activity adds a layer of caution worth noting. Chairman Henry Samueli sold nearly $67 million in shares across multiple tranches on June 24, and CLO Mark Brazeal has sold $29 million across three transactions since late June. These are sizable in absolute dollar terms. The 90-day net figure is technically positive at 733,000 shares due to grant activity, but the directional read from the largest individual holders is one of trimming into the recovery. BlackRock added 12.3 million shares in July, so institutional flow at the index level remains supportive — but the insider picture leans toward distribution near current prices.
The framework for the next three weeks is clear: the breakout from $360–$411 is intact, short sellers are absent, and the borrow market poses no friction. What September 2 brings on AI semiconductor revenue and gross margin guidance is the only variable that matters. The last two earnings prints both produced double-digit declines on day one — that reaction function is what the market is pricing around, and the put/call ratio's mild elevation suggests some are beginning to position for it.
See the live data behind this article on ORTEX.
Open AVGO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
